ADVB
Price
$9.60
Change
-$0.84 (-8.05%)
Updated
Sep 2, 04:56 PM (EDT)
Capitalization
17.25M
Intraday BUY SELL Signals
XGN
Price
$7.15
Change
-$0.19 (-2.59%)
Updated
Sep 1, 04:59 PM (EDT)
Capitalization
179.03M
76 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADVB vs XGN

ADVB vs XGN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ADVB vs. XGN commentary
Sep 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADVB is a StrongBuy and XGN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2026
Stock price -- (ADVB: $10.44 vs. XGN: $7.12)
Brand notoriety: ADVB and XGN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ADVB: 296% vs. XGN: 52%
Market capitalization -- ADVB: $17.25M vs. XGN: $173.21M
ADVB [@Medical Specialties] is valued at $17.25M. XGN’s [@Medical Specialties] market capitalization is $173.21M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $18.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADVB’s FA Score shows that 2 FA rating(s) are green whileXGN’s FA Score has 1 green FA rating(s).

  • ADVB’s FA Score: 2 green, 3 red.
  • XGN’s FA Score: 1 green, 4 red.
According to our system of comparison, ADVB is a better buy in the long-term than XGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADVB’s TA Score shows that 4 TA indicator(s) are bullish while XGN’s TA Score has 4 bullish TA indicator(s).

  • ADVB’s TA Score: 4 bullish, 4 bearish.
  • XGN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ADVB is a better buy in the short-term than XGN.

Price Growth

ADVB (@Medical Specialties) experienced а +13.73% price change this week, while XGN (@Medical Specialties) price change was -6.32% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.08%. For the same industry, the average monthly price growth was +11.48%, and the average quarterly price growth was +31.94%.

Reported Earning Dates

XGN is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Medical Specialties (+1.08% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XGN($179M) has a higher market cap than ADVB($17.2M). ADVB YTD gains are higher at: 78.890 vs. XGN (21.546).
ADVBXGNADVB / XGN
Capitalization17.2M179M10%
EBITDAN/A-12.76M-
Gain YTD78.89021.546366%
P/E Ratio2.61N/A-
RevenueN/A68.4M-
Total CashN/A21.5M-
Total DebtN/A25.4M-
FUNDAMENTALS RATINGS
XGN: Fundamental Ratings
XGN
OUTLOOK RATING
1..100
92
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
12

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADVBXGN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ADVB
Daily Signal:
Gain/Loss:
XGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLUEX31.31N/A
N/A
Fidelity Advisor Stk Selec Lg Cp Val C
SRUAX17.32N/A
N/A
Meeder Spectrum Adviser
JGRQX20.86N/A
N/A
JPMorgan Small Cap Growth R3
FSWCX16.77N/A
N/A
Fidelity SAI US Value Index
FSEPX17.22N/A
N/A
Fidelity Advisor Sustainable U.S. Eq M